TAKARA BIO INC.
4974・Prime Market・Chemicals
TAKARA BIO INC.4974
TAKARA BIO INC.4974
Reference Indicators
Market Cap
—
P/E (Forecast)
—
P/B
—
Dividend Yield (Forecast)
—
ROE
-8.8%
EV/EBITDA
—
Financial Summary
Unit: ¥M
| Item | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|
Net Sales | 67,699 | 78,142 | 43,505 | 45,039 | 40,318 |
Cost of Sales | 18,488 | 33,377 | 16,597 | 18,972 | 20,057 |
Gross Profit | 49,211 | 44,765 | 26,908 | 26,067 | 20,261 |
SG&A Expenses | 20,309 | 24,224 | 23,905 | 23,804 | 24,949 |
Operating Income | 28,902 | 20,541 | 3,003 | 2,263 | -4,688 |
Non-operating Income | 357 | 363 | 513 | 619 | 427 |
Non-operating Expenses | 800 | 221 | 111 | 289 | 732 |
Ordinary Income | 28,459 | 20,682 | 3,405 | 2,592 | -4,992 |
Extraordinary Income | 4,476 | 930 | 3 | 6 | 112 |
Extraordinary Losses | 5,403 | 388 | 554 | 601 | 4,319 |
Pre-tax Income | 27,532 | 21,224 | 2,853 | 1,997 | -9,200 |
Income Taxes | 7,624 | 5,176 | 1,343 | 910 | 353 |
Net Income | 19,849 | 16,012 | 1,480 | 1,041 | -9,599 |
EBITDA | 32,956 | 25,190 | 7,922 | 6,564 | 465 |
Gross Margin | 72.7% | 57.3% | 61.9% | 57.9% | 50.3% |
Operating Margin | 42.7% | 26.3% | 6.9% | 5.0% | -11.6% |
ROA | 17.2% | 12.4% | 1.2% | 0.8% | -7.2% |
ROE | 23.4% | 15.4% | 1.3% | 0.9% | -8.8% |